Kcentra 1,000 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBR8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,075
Award facts
- Contract value 100% obligated
- $72,075.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $72,075.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The delivery order, issued on December 17, 2025, with an ultimate completion date of January 9, 2026, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes regional prime vendor contractors to supply pharmaceutical products supporting Department of Defense healthcare operations.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with substantial contracting activity through the Defense Logistics Agency's Medical Supply Chain division. The company's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The parent Indefinite Delivery Contract, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, positioning DMS Pharmaceutical Group as a key pharmaceutical supplier for military healthcare facilities worldwide. No subcontractors are identified in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FFBR8?
SPE2DR26FFBR8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FFBR8 worth?
The government has obligated $72,075 on SPE2DR26FFBR8.
Is contract SPE2DR26FFBR8 an order under another contract?
Yes. SPE2DR26FFBR8 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBR8 competed?
The extent of competition for SPE2DR26FFBR8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award